1. Home
  2. SPCB vs HOWL Comparison

SPCB vs HOWL Comparison

Compare SPCB & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SuperCom Ltd. (Israel)

SPCB

SuperCom Ltd. (Israel)

N/A

Current Price

$8.36

Market Cap

57.4M

Sector

Technology

ML Signal

N/A

Logo Werewolf Therapeutics Inc.

HOWL

Werewolf Therapeutics Inc.

N/A

Current Price

$1.00

Market Cap

46.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SPCB
HOWL
Founded
1988
2017
Country
Israel
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
57.4M
46.7M
IPO Year
2004
2021

Fundamental Metrics

Financial Performance
Metric
SPCB
HOWL
Price
$8.36
$1.00
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $17.00
N/A
AVG Volume (30 Days)
45.6K
★ 398.3K
Earning Date
11-20-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 18.40
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$9.51
N/A
Revenue Next Year
$12.31
N/A
P/E Ratio
$10.36
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.07
$0.27
52 Week High
$12.87
$1.21

Technical Indicators

Market Signals
Indicator
SPCB
HOWL
Relative Strength Index (RSI) 34.96 50.00
Support Level $7.95 $0.88
Resistance Level $8.69 $1.12
Average True Range (ATR) 0.45 0.06
MACD -0.10 -0.01
Stochastic Oscillator 4.99 33.40

Price Performance

Historical Comparison
SPCB
HOWL

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.

Share on Social Networks: